search
Back to results

Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation

Primary Purpose

Gingival Diseases

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Xenogeneic Collagen Matrix
Free Gingival Graft
Sponsored by
Perio Health Professionals, PLLC
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gingival Diseases focused on measuring Autologous; Collagen Matrix; Keratinized Tissue

Eligibility Criteria

8 Years - 70 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • At least two non-adjacent teeth in contralateral quadrants of the same jaw with < 2mm of KT that requires soft tissue grafting (1-4 teeth may be treated). In case of adjacent teeth requiring grafting, only one tooth at each site will act as test or control tooth, but all teeth will get the same treatment). The number of teeth treated must be the same on the test and control sites.

    • Root coverage is not desired at the time of grafting.
    • Females of childbearing potential must have a documented negative urine pregnancy test.
    • Read, understood and signed an institutional review board (IRB) approved Informed Consent Form (ICF).
    • Able and willing to follow study procedures and instructions.
    • Multi-rooted teeth may be treated but will not be included as study teeth

Exclusion Criteria:

  • Vestibule depth of less than 7mm from base of recession, and/or teeth with Miller Grade 2 or higher mobility.

    • Any systemic conditions (i.e., diabetes mellitus, cancer, HIV, bone metabolic diseases) that could compromise wound healing and/ or preclude periodontal surgery; or who are currently receiving or have received within two months prior to study entry, systemic corticosteroids, immunosuppressive agents, radiation therapy, and/or chemotherapy which could compromise wound healing and preclude periodontal surgery.
    • Presence of acute infectious lesions in the areas intended for surgery.
    • History of any tobacco use within the last six months.
    • Taking intramuscular or intravenous bisphosphonates.
    • Known hypersensitivity to collagen products, and/or allergy to iodine or shellfish.
    • Participating in other clinical studies involving therapeutic intervention (either medical or dental).
    • Previously undergone a gingival grafting procedure on the test or control teeth or the teeth adjacent to the study site.
    • Female subjects who are pregnant or lactating, or who intend to become pregnant during the study duration following entrance into the study.
    • Subjects, who in the opinion of the investigator, for any reason other than those listed above, will not be able to complete the study per protocol.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    xenogeneic collagen matrix

    Free Gingival Graft

    Arm Description

    Xenogeneic collagen matrix device placed on treatment wound bed site

    Traditional free gingival graft (autogenous graft device harvested from patient's palate) placed on treatment site wound bed

    Outcomes

    Primary Outcome Measures

    Keratinized Tissue Width
    Change in Keratinized Tissue width

    Secondary Outcome Measures

    Full Information

    First Posted
    September 24, 2013
    Last Updated
    May 24, 2014
    Sponsor
    Perio Health Professionals, PLLC
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01952301
    Brief Title
    Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation
    Official Title
    A Randomized, Controlled Clinical Trial to Evaluate a Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2014
    Overall Recruitment Status
    Completed
    Study Start Date
    November 2010 (undefined)
    Primary Completion Date
    October 2011 (Actual)
    Study Completion Date
    January 2012 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Perio Health Professionals, PLLC

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    A split-mouth study comparing soft tissue augmentation results using free gingival graft (FGG) versus xenogeneic collagen matrix (CM) for the generation of keratinized tissue (KT) around teeth with insufficient (< 2mm) KT.
    Detailed Description
    A single-blind, randomized, controlled, split-mouth study of 30 subjects with insufficient zones of KT (< 2mm). The study utilized a within subject treatment comparison design to establish non-inferiority of the test (CM) versus control (FGG) therapy. The primary efficacy endpoint was KT width at 6-months. Secondary endpoints included traditional periodontal measures, such as clinical attachment, recession and bleeding on probing. Patient reported pain, discomfort and esthetic satisfaction were also recorded. Biopsies were obtained at 6-months.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Gingival Diseases
    Keywords
    Autologous; Collagen Matrix; Keratinized Tissue

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    30 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    xenogeneic collagen matrix
    Arm Type
    Active Comparator
    Arm Description
    Xenogeneic collagen matrix device placed on treatment wound bed site
    Arm Title
    Free Gingival Graft
    Arm Type
    Active Comparator
    Arm Description
    Traditional free gingival graft (autogenous graft device harvested from patient's palate) placed on treatment site wound bed
    Intervention Type
    Device
    Intervention Name(s)
    Xenogeneic Collagen Matrix
    Intervention Description
    A type I and III porcine collagen matrix, as cleared by FDA (K012423)
    Intervention Type
    Device
    Intervention Name(s)
    Free Gingival Graft
    Other Intervention Name(s)
    Free Autogenous Graft
    Intervention Description
    Autogenous, full-thickness soft tissue graft harvested from patient's palate.
    Primary Outcome Measure Information:
    Title
    Keratinized Tissue Width
    Description
    Change in Keratinized Tissue width
    Time Frame
    6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    8 Years
    Maximum Age & Unit of Time
    70 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: At least two non-adjacent teeth in contralateral quadrants of the same jaw with < 2mm of KT that requires soft tissue grafting (1-4 teeth may be treated). In case of adjacent teeth requiring grafting, only one tooth at each site will act as test or control tooth, but all teeth will get the same treatment). The number of teeth treated must be the same on the test and control sites. Root coverage is not desired at the time of grafting. Females of childbearing potential must have a documented negative urine pregnancy test. Read, understood and signed an institutional review board (IRB) approved Informed Consent Form (ICF). Able and willing to follow study procedures and instructions. Multi-rooted teeth may be treated but will not be included as study teeth Exclusion Criteria: Vestibule depth of less than 7mm from base of recession, and/or teeth with Miller Grade 2 or higher mobility. Any systemic conditions (i.e., diabetes mellitus, cancer, HIV, bone metabolic diseases) that could compromise wound healing and/ or preclude periodontal surgery; or who are currently receiving or have received within two months prior to study entry, systemic corticosteroids, immunosuppressive agents, radiation therapy, and/or chemotherapy which could compromise wound healing and preclude periodontal surgery. Presence of acute infectious lesions in the areas intended for surgery. History of any tobacco use within the last six months. Taking intramuscular or intravenous bisphosphonates. Known hypersensitivity to collagen products, and/or allergy to iodine or shellfish. Participating in other clinical studies involving therapeutic intervention (either medical or dental). Previously undergone a gingival grafting procedure on the test or control teeth or the teeth adjacent to the study site. Female subjects who are pregnant or lactating, or who intend to become pregnant during the study duration following entrance into the study. Subjects, who in the opinion of the investigator, for any reason other than those listed above, will not be able to complete the study per protocol.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Michael K McGuire, DDS
    Organizational Affiliation
    Perio Health Professionals
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    24597764
    Citation
    McGuire MK, Scheyer ET. Randomized, controlled clinical trial to evaluate a xenogeneic collagen matrix as an alternative to free gingival grafting for oral soft tissue augmentation. J Periodontol. 2014 Oct;85(10):1333-41. doi: 10.1902/jop.2014.130692. Epub 2014 Mar 5.
    Results Reference
    derived

    Learn more about this trial

    Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation

    We'll reach out to this number within 24 hrs